Long-term efficacy, safety, and side effect profile of botulinum toxin in dystonia: a 20-year follow-up.
about
Botulinum Neurotoxin Type A in Neurology: UpdateLong-term tremor therapy for Parkinson and essential tremor with sensor-guided botulinum toxin type A injections.Etiology, Diagnosis and Management of Oromandibular Dystonia: an Update for Stomatologists.Comparable Botulinum Toxin Outcomes between Primary and Secondary Blepharospasm: A Retrospective AnalysisReduced Neck Muscle Strength and Altered Muscle Mechanical Properties in Cervical Dystonia Following Botulinum Neurotoxin Injections: A Prospective StudyOccurrence of Dysphagia Following Botulinum Toxin Injection in Parkinsonism-related Cervical Dystonia: A Retrospective Study.Therapeutic advances in dystonia.Clinical and scientific perspectives on movement disorders: Stanley Fahn's contributions.Determinants of botulinum toxin discontinuation in multiple sclerosis: a retrospective study.Botulinum toxin: State of the art.Blepharospasm 40 years later.Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology.Real-World, Long-Term Quality of Life Following Therapeutic OnabotulinumtoxinA Treatment.A Highly Specific Monoclonal Antibody for Botulinum Neurotoxin Type A-Cleaved SNAP25.Botulinum Toxin in Secondarily Nonresponsive Patients with Spasmodic Dysphonia.Long-term Efficacy of Botulinum Neurotoxin-A Treatment for Essential Blepharospasm.Longitudinal studies of botulinum toxin in cervical dystonia: Why do patients discontinue therapy?[Modern non-cosmetic treatment with botulinum toxins].Can botulinum toxin cause chronic muscle weakness?Long-Term Abobotulinumtoxin A Treatment of Cervical Dystonia.Spasmodic dysphonia follow-up with videolaryngoscopy and voice spectrography during treatment with botulinum toxin.Botulinum Toxin Induced Atrophy: An Uncharted Territory
P2860
Q26781047-7638AD19-2C00-4204-B274-D260BC5F85EEQ33769128-C968AA9D-B0E9-415F-AAB7-B873B348715AQ33777409-14AF0278-F864-44C7-B4BF-8AD4E89ADD71Q34704553-0BD53F16-B5B8-4DAD-82E2-19BCF4667CAFQ36526274-A6B621EC-EE69-4812-850A-191C32AA5A98Q37400295-970209D1-56E7-40B0-A178-DE81DB396731Q38572489-B16525D4-2AB2-4C03-9673-888C6C12C887Q38610367-6C3218D1-D4AF-4B7E-B34A-2C3D3836D712Q38647620-9047A3B9-B1DD-438B-A690-BEFB1384C985Q38668149-880C613B-4289-451E-AF65-2B04A87246C8Q39130169-5F064646-2817-43CE-AC36-5E2A33E51323Q39207459-6E974EE9-46E6-4943-8CCC-21F6E1144428Q39588636-0C879BED-338E-4AF2-B257-C60BCC330AE9Q42396665-ED0A855C-644A-42F2-B3C6-364E203559B2Q46104554-942C78AD-F378-4232-A352-91EDA128C5E9Q47548529-DDBC53F9-ABA7-4686-A753-FE4BA2C2FDF8Q48008185-735EE95A-09CD-4CED-823F-C2F65AFF9289Q48556994-1FC3C86E-5226-4908-B63E-312755716C30Q50098828-A14D03BE-2A62-4290-A52B-1AAE59F3B982Q50668003-85D29383-745F-47FF-BAEF-98879BF3AFD1Q53509186-A1FAF174-74E5-4A88-A869-00F1E44EED83Q57171247-696BE0E9-FA68-45AC-A48F-5976682F74F3
P2860
Long-term efficacy, safety, and side effect profile of botulinum toxin in dystonia: a 20-year follow-up.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Long-term efficacy, safety, an ...... dystonia: a 20-year follow-up.
@en
Long-term efficacy, safety, an ...... dystonia: a 20-year follow-up.
@nl
type
label
Long-term efficacy, safety, an ...... dystonia: a 20-year follow-up.
@en
Long-term efficacy, safety, an ...... dystonia: a 20-year follow-up.
@nl
prefLabel
Long-term efficacy, safety, an ...... dystonia: a 20-year follow-up.
@en
Long-term efficacy, safety, an ...... dystonia: a 20-year follow-up.
@nl
P1433
P1476
Long-term efficacy, safety, an ...... dystonia: a 20-year follow-up.
@en
P2093
Juan Ramirez-Castaneda
P304
P356
10.1016/J.TOXICON.2014.07.009
P577
2014-08-15T00:00:00Z